Using an interdisciplinary approach, the Crary laboratory is unravelling the molecular changes occurring in diseases with neurofibrillary tangles composed of the tau protein (i.e., tauopathies). This diverse group of brain diseases includes Alzheimer’s disease, movement disorders and chronic traumatic encephalopathy. The laboratory uses histological, genetic, biochemical and molecular approaches to pinpoint underlying molecular and cellular triggers of these diseases.

To learn more about our research, click here to visit the laboratory website.